Spring To Life Conference on Hematologic Malignancies: Conference on Indolent Lymphoid Malignancies
Ira Zackon, MD; Courtney Bellomo, MD; Pooja Chaukiyal, MD; Edward Dick, LCSW; Mary Jo Tomlinson, RN, BSN, OCN; Jenifer Brown, MD, PhD; Jonathan W. Friedberg, MD
Interested In Attending This Event?
Additional Registration Information:
Spring to Life Conference on Hematologic Malignancies: Conference on Indolent Lymphoid Malignancies is an accredited, educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty for the academic research, and community practice settings.
With programming for both healthcare professionals and the community, the goal of this one-day activity is to bring together cancer care providers and members of the community, including patients, survivors, their family, and care givers, to gain an up-to-date understanding of blood cancers, including ongoing research, clinical management, and emerging therapies. The program also provides perspectives on the impact of cancer on the lives of patients and families. The 2018 conference will focus on indolent lymphoid malignancies. Specifically, clinician sessions will detail standards of care and current evidence-based and emerging therapeutics, including efficacy, safety and tolerability, in order to inform a clinical audience on the more common indolent lymphomas and chronic lymphocytic leukemia. The theme of the afternoon patient program is Finding Hope in Times of Transition. Healthcare professionals are welcome and encouraged to participate in the afternoon patient- centered sessions. You will reeive additional informatio about this program after registering for the conference.
There is no fee to participate.